Large unilamellar vesicles (LUV): Began Phase II trial

Esperion Therapeutics Inc. (ESPR), Ann Arbor, Mich.

Read the full 75 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE